MEHMET KIVRAK | Biology and Life Sciences | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

MEHMET KIVRAK
Affiliation Recep Tayyip Erdogan University
Country Turkey
Scopus ID 57211715569
Documents 22
Citations 92
h-index 4
Subject Area Biology and Life Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0002-2405-8552

MEHMET KIVRAK

Recep Tayyip Erdogan University, Turkey

MEHMET KIVRAK is a researcher affiliated with Recep Tayyip Erdogan University whose scholarly work focuses on Biology and Life Sciences with interdisciplinary applications in clinical medicine, women’s health, artificial intelligence-assisted healthcare, and biomarker discovery. His research portfolio demonstrates consistent contributions to observational clinical studies and translational biomedical investigations published in peer-reviewed international journals.[1]

Abstract

This article summarizes the academic profile of MEHMET KIVRAK in relation to the Innovative Research Award. His published work spans clinical medicine, reproductive health, inflammatory biomarkers, cardiovascular risk assessment, and explainable artificial intelligence. The available publication record indicates sustained engagement in evidence-based biomedical research and collaboration across multiple clinical specialties, contributing to improved understanding of disease mechanisms and patient care.[2]

Keywords

Biology and Life Sciences; Clinical Medicine; Biomarkers; Artificial Intelligence; Women’s Health; Cardiovascular Risk; Medical Research.

Introduction

Modern biomedical research increasingly combines clinical observations with computational analysis to improve diagnosis and treatment. MEHMET KIVRAK has participated in investigations involving pregnancy-related disorders, polycystic ovary syndrome, dermatological diseases, and neurodevelopmental conditions. These studies illustrate an interdisciplinary approach integrating laboratory findings with clinical outcomes.[3]

Research Profile

According to the available author metrics, the researcher has produced 22 indexed documents receiving 92 citations with an h-index of 4. The research emphasizes prospective observational studies, biomarker evaluation, clinical epidemiology, and the application of explainable artificial intelligence to healthcare datasets. These activities reflect continued participation in internationally indexed scientific publishing.[1]

Research Contributions

  • Clinical investigations of hypertensive disorders during pregnancy and urinary health.
  • Evaluation of inflammatory biomarkers including IL-39 in polycystic ovary syndrome.
  • Explainable artificial intelligence for cardiovascular risk prediction in psoriasis.
  • Clinical follow-up studies examining ADHD treatment outcomes and emotional regulation.

Publications

  • Lower Urinary Tract System Symptoms and Urinary Incontinence in Hypertensive Disorders of Pregnancy (2026).
  • Evaluation of Serum IL-39 Levels in Patients with Polycystic Ovary Syndrome (2026).
  • Unveiling Key Biomarkers of Cardiovascular Risk in Psoriasis Through Explainable Artificial Intelligence (2026).
  • Associations with Methylphenidate Treatment in Emotion Regulation and Skin-Picking Severity in Adolescents with ADHD (2026).
  • Rize Bölgesindeki Gebelerde Emesis Gravidarum Prevalansı (2025).

Research Impact

The publication record demonstrates continuing contributions to clinical medicine and life sciences through peer-reviewed journals. Research outputs support understanding of women’s health, inflammatory mechanisms, predictive analytics, and evidence-based patient management. Citation activity indicates scholarly visibility and growing engagement within the international biomedical research community.[4]

Award Suitability

The research profile aligns with the objectives of the Global Innovation Technologist Awards by demonstrating interdisciplinary scientific investigation, peer-reviewed publication activity, and contributions to translational biomedical research. The combination of clinical expertise and emerging analytical methodologies represents a suitable basis for academic recognition within innovation-focused award programs.[5]

Conclusion

MEHMET KIVRAK’s scholarly activities reflect an emphasis on clinically relevant biomedical research supported by peer-reviewed publications and measurable research metrics. The available evidence highlights sustained contributions to Biology and Life Sciences while promoting interdisciplinary approaches that integrate clinical investigation with innovative analytical techniques.

References

  1. Elsevier. Scopus Author Details: MEHMET KIVRAK, Author ID 57211715569.
    https://www.scopus.com/pages/authors/57211715569
  2. Journal of Clinical Medicine. Lower Urinary Tract System Symptoms and Urinary Incontinence in Hypertensive Disorders of Pregnancy.
    https://doi.org/10.3390/jcm15114162
  3. Journal of Clinical Medicine. Evaluation of Serum IL-39 Levels in Patients with Polycystic Ovary Syndrome.
    https://doi.org/10.3390/jcm15103958
  4. Biology. Unveiling Key Biomarkers of Cardiovascular Risk in Psoriasis Through Explainable Artificial Intelligence.
    https://doi.org/10.3390/biology15070532
  5. Journal of Clinical Medicine. Associations with Methylphenidate Treatment in Emotion Regulation and Skin-Picking Severity in Adolescents with ADHD.
    https://doi.org/10.3390/jcm15062401
  6. Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi. Rize Bölgesindeki Gebelerde Emesis Gravidarum Prevalansı.
    https://doi.org/10.17517/ksutfd.1621762

Shuai Li | Biology and Life Sciences | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

Shuai Li
Regeneron, United States
Shuai Li
Affiliation Regeneron
Country United States
Scopus ID 60597499200
Documents 6
Citations 221
h-index 4
Subject Area Biology and Life Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0002-1537-3956

The Innovative Research Award recognizes the scholarly and scientific contributions of Shuai Li, a researcher associated with Regeneron and previously affiliated with Duke University. Li has contributed to interdisciplinary research spanning synthetic biology, metabolic engineering, supramolecular chemistry, and automated bioprocess technologies. The research portfolio demonstrates a combination of experimental innovation, engineering methodology, and translational biological applications within the broader field of biology and life sciences.[1]

Abstract

Shuai Li has developed a multidisciplinary academic profile integrating biological engineering, synthetic biology, supramolecular chemistry, and automation systems for laboratory applications. Published works include contributions to metabolic engineering in Escherichia coli, chiral molecular assemblies, CRISPR-associated biological systems, and open-source laboratory automation. The body of work reflects ongoing efforts to optimize biological production systems, enhance molecular recognition strategies, and improve accessibility to bioprocess instrumentation.[2][3]

Keywords

Synthetic Biology; Metabolic Engineering; Bioprocess Automation; Supramolecular Chemistry; CRISPR Systems; NADPH Flux; Chiroptical Switches; Biological Engineering; Automated Sampling Systems; Life Sciences Research.

Introduction

Contemporary life sciences research increasingly depends upon interdisciplinary approaches that integrate chemistry, engineering, automation, and computationally informed biological experimentation. Shuai Li’s scholarly contributions reflect this evolving research landscape through work involving engineered microbial systems, supramolecular interfaces, and laboratory automation platforms.[4]

Li completed academic training at Shandong University and the Institute of Chemistry of the Chinese Academy of Sciences before continuing research activities at Duke University. These educational and research experiences contributed to a broad methodological background that spans chemical sciences and biotechnology-oriented engineering disciplines.[1]

Research Profile

The Scopus author profile associated with Shuai Li reports 221 citations across multiple indexed documents and an h-index of 4, indicating measurable academic engagement and scholarly visibility within biotechnology and chemistry-related research communities.[1]

Research topics explored by Li include metabolic pathway optimization, enzyme regulation, supramolecular assembly, CRISPR/Cas systems, and automated sampling technologies for bioreactors. Publications demonstrate collaborations across academic laboratories and interdisciplinary scientific environments.[5]

  • Research specialization in synthetic biology and metabolic engineering.
  • Contributions to supramolecular and chiral chemistry methodologies.
  • Development of low-cost automated laboratory technologies.

Research Contributions

Among Li’s notable contributions is the development of the BioSamplr, an open-source automated sampling system designed for bioreactors. The platform aimed to provide a lower-cost alternative for laboratory sampling automation, thereby increasing accessibility for smaller research laboratories and educational institutions.[2]

Li also contributed to research focused on improving NADPH flux and xylitol biosynthesis in engineered E. coli systems through dynamic regulatory control strategies. This work addressed feedback regulation mechanisms and metabolic optimization relevant to industrial biotechnology applications.[3]

Additional studies investigated CRISPR-associated endonuclease complexes and their effects on self-targeting spacer stability. These findings contributed to understanding microbial genome regulation and CRISPR system functionality.[6]

In the field of supramolecular chemistry, Li co-authored studies examining chiroptical switches, chiral metallogels, and self-assembled polydiacetylene systems for enantioselective recognition. These works demonstrated applications of molecular self-assembly and chirality transfer in advanced chemical systems.[7][8]

Publications

  1. BioSamplr: An open source, low cost automated sampling system for bioreactors — HardwareX (2021).
  2. Dynamic control over feedback regulatory mechanisms improves NADPH flux and xylitol biosynthesis in engineered E. coli — Metabolic Engineering (2021).
  3. Escherichia coli Cas1/2 Endonuclease Complex Modifies Self-Targeting CRISPR/Cascade Spacers Reducing Silencing Guide Stability — ACS Synthetic Biology (2020).
  4. Supramolecular chiroptical switches — Chemical Society Reviews (2020).
  5. Self-Assembled Polydiacetylene Vesicle and Helix with Chiral Interface for Visualized Enantioselective Recognition of Sulfinamide — ACS Applied Materials & Interfaces (2017).

Research Impact

The academic impact of Li’s work is reflected through citations, interdisciplinary collaborations, and publication in peer-reviewed journals covering biotechnology, synthetic biology, materials science, and supramolecular chemistry. Research outputs have relevance for both academic investigation and industrial biotechnology applications.[3][7]

The integration of engineering principles with biological systems research has contributed to emerging methodologies in automated experimentation and metabolic pathway optimization. Such interdisciplinary work supports broader scientific efforts aimed at improving efficiency, reproducibility, and accessibility in laboratory research environments.[2]

Award Suitability

Shuai Li’s multidisciplinary research background aligns with the objectives of the Global Innovation Technologist Awards, which recognize scientific and technological advancements with measurable academic and practical significance. Contributions spanning metabolic engineering, CRISPR research, supramolecular chemistry, and open-source automation technologies demonstrate consistent engagement with innovation-oriented scientific inquiry.[1]

The combination of peer-reviewed publications, measurable citation performance, and interdisciplinary technical expertise supports recognition within the field of biology and life sciences. Li’s work illustrates the integration of engineering design principles with biological and chemical sciences to address contemporary research challenges.[4]

Conclusion

The scholarly profile of Shuai Li reflects interdisciplinary scientific engagement across synthetic biology, supramolecular chemistry, and laboratory engineering technologies. Through publications in recognized journals and contributions to biological automation systems, Li has participated in research initiatives with relevance to modern biotechnology and life sciences. The body of work demonstrates methodological diversity, collaborative scientific activity, and continuing participation in innovation-oriented academic research.[1][2]

References

  1. Elsevier. (n.d.). Scopus author details: Shuai Li, Author ID 60597499200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=60597499200
  2. Li, S. et al. (2021). BioSamplr: An open source, low cost automated sampling system for bioreactors. HardwareX.
    https://doi.org/10.1016/j.ohx.2021.e00177
  3. Li, S. et al. (2021). Dynamic control over feedback regulatory mechanisms improves NADPH flux and xylitol biosynthesis in engineered E. coli. Metabolic Engineering.
    https://doi.org/10.1016/j.ymben.2021.01.005
  4. ORCID. (n.d.). Shuai Li ORCID profile and educational background.
    https://orcid.org/0000-0002-1537-3956
  5. Crossref Metadata Search. (n.d.). Publication metadata associated with Shuai Li.
  6. Li, S. et al. (2020). Escherichia coli Cas1/2 Endonuclease Complex Modifies Self-Targeting CRISPR/Cascade Spacers Reducing Silencing Guide Stability. ACS Synthetic Biology.
    https://doi.org/10.1021/acssynbio.0c00398
  7. Li, S. et al. (2020). Supramolecular chiroptical switches. Chemical Society Reviews.
    https://doi.org/10.1039/d0cs00191k
  8. Li, S. et al. (2017). Alanine-Based Chiral Metallogels via Supramolecular Coordination Complex Platforms: Metallogelation Induced Chirality Transfer. Journal of the American Chemical Society.
    https://doi.org/10.1021/jacs.7b10769

Mahir Sharif | Bioinformatics | Best Researcher Award

Published on by Innovation Technologist

Assist. Prof. Dr. Mahir Sharif | Bioinformatics | Best Researcher Award

Prince Sattam ibn Abdelaziz University | Saudi Arabia

Dr. Mahir M. Sharif is an accomplished academic and researcher in the field of Computer Science, specializing in Computational Intelligence and Bioinformatics. He has extensive experience in academia, research, and administration, complemented by leadership roles in multiple universities and colleges. His career reflects a strong commitment to innovation, digital transformation, and applied research in artificial intelligence, deep learning, and assistive technologies.

Publication Profile 

Scopus

Educational Background 

He holds a Ph.D. in Computer Science with a specialization in Computational Intelligence and Bioinformatics from Cairo University. He also earned an M.Sc. in Computer Science from Elneelain University and a B.Sc. in Computer Science from Omdurman Islamic University with distinction.

Professional Experience 

Dr. Sharif has served as an Associate Professor of Computer Science at Stars College for Medical Science and Technology and has held several academic positions, including Assistant Professor at Omdurman Islamic University, Prince Sattam ibn Abdel Aziz University, and other institutions. He has extensive teaching experience in computer science and has contributed as a professional trainer in computer skills and applications. Additionally, he has significant administrative experience, serving as Dean, Deputy Dean, and Head of Departments in various faculties, where he demonstrated strong leadership in academic governance and program development.

Research Interests 

His research focuses on artificial intelligence, deep learning, computational intelligence, bioinformatics, assistive technologies, and smart systems. His recent work includes developing advanced object detection models for visually impaired individuals, enhancing cybersecurity threat detection, and exploring AI-driven applications in IoT and smart cities.

Awards and Honors 

Dr. Sharif has received recognition for his contributions to academia and research through leadership roles, membership in scientific councils, and participation in international conferences and research forums. He has also led and contributed to several funded research projects, notably in AI-driven accessibility technologies and digital platforms for data management.

Research Skills 

He possesses strong expertise in artificial intelligence, machine learning, deep learning algorithms, object detection systems, computational modeling, bioinformatics, and the design of smart solutions. His skills also extend to managing research projects, supervising postgraduate research, and implementing innovative technology-driven approaches to real-world problems.

Publications 

  1. Leveraging Assistive Technology for Visually Impaired People Through Optimal Deep Transfer Learning Based Object Detection Model
    Year: 2025

  2. Advanced object detection for smart accessibility: a Yolov10 with marine predator algorithm to aid visually challenged people
    Year: 2025

  3. Feature enhancement model with up sampling based cyber threat attack detection and classification on imbalanced dataset in Industrial Internet of Things
    Year: 2025

  4. IoT in urban development: insight into smart city applications, case studies, challenges, and future prospects
    Year: 2025

  5. Artificial intelligence with greater cane rat algorithm driven robust speech emotion recognition approach
    Year: 2025

Conclusion 

Dr. Mahir M. Sharif exemplifies a dedicated researcher and academic leader with a strong track record in teaching, research, and administration. His contributions to artificial intelligence applications, assistive technologies, and digital innovation demonstrate his capability to bridge academic research with societal impact. His leadership in funded projects and involvement in international collaborations further highlights his commitment to advancing knowledge and technology for the betterment of education and community development.